<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of this study was to analyze the pattern of <z:hpo ids='HP_0000554'>uveitis</z:hpo> in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease in Tunisia, North Africa </plain></SENT>
<SENT sid="1" pm="."><plain>We retrospectively reviewed the clinical records of 62 patients (111 eyes) diagnosed with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's <z:hpo ids='HP_0000554'>uveitis</z:hpo> (BU) at the Department of Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia, between January 1995 and December 2006 </plain></SENT>
<SENT sid="2" pm="."><plain>Forty-seven of 62 patients (75.8%) were men and 15 (24.2%) were women </plain></SENT>
<SENT sid="3" pm="."><plain>Mean age at <z:hpo ids='HP_0003674'>onset</z:hpo> was 29.3 years </plain></SENT>
<SENT sid="4" pm="."><plain>The average follow-up was 75.6 months </plain></SENT>
<SENT sid="5" pm="."><plain>The most common extraocular clinical manifestations were recurrent <z:hpo ids='HP_0000155'>oral ulcer</z:hpo> in <z:hpo ids='HP_0000001'>all</z:hpo> patients and <z:e sem="disease" ids="C0406191" disease_type="Disease or Syndrome" abbrv="">pseudofolliculitis</z:e> in 52 patients (83.9%) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000554'>Uveitis</z:hpo> was bilateral in 79% </plain></SENT>
<SENT sid="7" pm="."><plain>Initial best-corrected visual acuity was &gt; or =20/40 in 41 affected eyes (36.9%) and &lt;20/200 in 49 affected eyes (44.2%) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0012121'>Panuveitis</z:hpo> (68 eyes, 61.3%) and <z:hpo ids='HP_0012123'>posterior uveitis</z:hpo> (38 eyes, 34.2%) were the most common forms, followed by <z:hpo ids='HP_0012122'>anterior uveitis</z:hpo> (five eyes, 4.5%) </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="46" ids="15035">Retinal</z:chebi> <z:hpo ids='HP_0002633'>vasculitis</z:hpo> was found in 89 eyes (80.2%) </plain></SENT>
<SENT sid="10" pm="."><plain>Most common complications included <z:e sem="disease" ids="C0152253" disease_type="Disease or Syndrome" abbrv="">posterior synechiae</z:e> (32.4%), <z:hpo ids='HP_0000518'>cataract</z:hpo> (31.5%), and <z:hpo ids='HP_0011505'>cystoid macular edema</z:hpo> (19.8%) </plain></SENT>
<SENT sid="11" pm="."><plain>Systemic <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> were administered in 58 patients (93.5%) </plain></SENT>
<SENT sid="12" pm="."><plain>Immunosuppressive drugs were used in 22 patients (35.5%) </plain></SENT>
<SENT sid="13" pm="."><plain>Fifty-six affected eyes (50.5%) had final visual acuity &gt; or =20/40 and 34 affected eyes (30.6%) had final visual acuity &lt;20/200 </plain></SENT>
<SENT sid="14" pm="."><plain>In Tunisia, BU affects predominantly young men </plain></SENT>
<SENT sid="15" pm="."><plain>Bilateral <z:hpo ids='HP_0012121'>panuveitis</z:hpo> associated with <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:hpo ids='HP_0002633'>vasculitis</z:hpo> was the most common ocular manifestation </plain></SENT>
<SENT sid="16" pm="."><plain>More than 50% of patients maintained a visual acuity of 20/40 or better, and immunosuppressive therapy probably contributed to the improvement of visual prognosis of these patients </plain></SENT>
</text></document>